News Briefs

Australian-Developed HIV Vaccine Trial Announced

June 4, 2003

This article is part of The Body PRO's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.

In Sydney today, the Australian-Thai HIV Vaccine Consortium announced that recruitment of volunteers has begun for the first clinical trials of a new Australian-developed HIV vaccine. The trial, to take place at Sydney's St. Vincent's Hospital, will involve 24 HIV-negative volunteers. "We will be able to undertake a range of sophisticated laboratory tests to determine if the vaccines stimulate the human immune system to produce anti-HIV responses," said principal investigator Dr. Tony Kelleher of the University of New South Wales. The vaccine is based on "prime and boost" technology, which combines modified HIV DNA with a fowl pox virus. Results are expected by the end of the year. The trial is funded by a grant from the U.S. National Institutes of Health and the Australian government.

Back to other CDC news for June 4, 2003

Previous Updates

Adapted from:
Australian Associated Press

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.